Form D · Biotechnology
EMULATE THERAPEUTICS, INC.
Seattle, WA · CIK 0001254348
Offering snapshot reported Sep 20, 2019 · SEC filing
- Reported sold
- $450K Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 6, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 20, 2019 | Initial | $450,000 | No comparison | 2 | SEC filing |
| Nov 19, 2018 | Amendment | $4,117,760 | $3,117,760vs Nov 20, 2017 | 33 | SEC filing |
| Nov 20, 2017 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| May 19, 2017 | Initial | $210,000 | No comparison | 5 | SEC filing |
| Feb 23, 2017 | Amendment | $9,618,795 | $9,368,795vs Dec 24, 2015 | 49 | SEC filing |
| Dec 24, 2015 | Initial | $250,000 | No comparison | 2 | SEC filing |
| Jun 23, 2015 | Initial | $725,000 | No comparison | 4 | SEC filing |
| Jul 21, 2014 | Amendment | $11,480,715 | $2,319,301vs Feb 10, 2014 | 39 | SEC filing |
| Feb 10, 2014 | Initial | $9,161,414 | No comparison | 32 | SEC filing |
| Apr 13, 2010 | Initial | $300,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-349360
Source: Form D, filed Sep 20, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bennett M Butters | Director |
| Lisa C Butters | Director |
| John T Butters | Director, Executive |
| Andy Daniels | Director |
| Clark W Donnell | Director |
| David Grieger | Director |
| Dave Grieger | Director |
| Dick Henriques | Director |
| Sean Kell | Director |
| John E Kingma | Director |
| Daniel Kisner | Director |
| Charles Mcnerney | Director |
| Charles Mc Nerney | Director |
| Nancy Nordhoff | Director |
| John S Payne | Director |
| Steven E Pope | Executive |
| Chris Rivera | Director, Executive |
| Una Ryan | Director |
| Michael K. Ullman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
425 Pontius Avenue North, Suite 200
Seattle, WA, 98109
Seattle, WA, 98109